Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

BioWin Expands Its »Growth & Financing« Member Service (2022-11-29)
Nadia Verwilghen and Bernard Linsmeau will lead service offer to support biotech and medtech companies in accelerating business growth and raising funds in challenging markets BioWin, the health cluster of Wallonia, today announces the appointment of two growt...
AstraZeneca Acquires Neogene: up to $320m with $200m Upfront (2022-11-29)
Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumours AstraZeneca today announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company p...
Full-Life Technologies Acquires Focus-X Tx for up to $245m (2022-11-29)
Acquisition accelerates Full-Life’s transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Development Platform Full-Life Technologies, a fully integrated global radiotherapeutics company, today anno...
Sotio Exercises Option for Novel ADC with LegoChem (2022-11-29)
> SOT106 is an antibody-drug conjugate (ADC) targeting an attractive surface antigen expressed on multiple solid tumors. > Preclinical efficacy and tolerability studies of SOT106 show promising results across multiple solid tumor indications and a beneficial the...
Hemispherian Closes 1st NOK30m Tranche of Series A1 Round (2022-11-24)
Hemispherian AS (“Hemispherian” or the “Company”), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure of the first tranche of its series A1 financing r...
Catalym Closes €50m Series C Led by Brandon Capital & Jeito (2022-11-22)
CatalYm today announced the close of a EUR 50 million (USD 49 million) Series C financing round. The oversubscribed round was co-led by new investors, Brandon Capital and Jeito Capital with participation from existing investors Forbion, Novartis Venture Fund, Vesal...
Uniqure & CSL: FDA Approves Gene Therapy for Hemophilia B (2022-11-22)
> Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX levels > uniQure conducted the multi-year clinical development pro...
Cradle Bio Emerges from Stealth with €5.5m in Seed Funding (2022-11-17)
> Cradle’s design platform makes it easy for everyone to start building products with biology instead of oil or animals, leveraging generative machine learning models to transform how biologists design and optimize proteins > Synthetic biology can generate envir...
FundaMental Pharma Launches with €10m in Seed Financing (2022-11-17)
FundaMental Pharma GmbH (“FundaMental”), a preclinical neuroscience company spun out of Heidelberg University, today announces that it has launched with EUR 10 million in seed financing led by BioGeneration Ventures (BGV) and Thuja Capital, with participation from ...
Azenta & Luxembourg Announce Memorandum of Understanding (2022-11-08)
Azenta, Inc. (Nasdaq: AZTA) and the Government of Luxembourg today announced the signing of a Memorandum of Understanding ("MoU") to facilitate continued healthcare technology development in Luxembourg. The Minister of the Economy of Luxembourg, Mr. Franz Fayot, an...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)